🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will collect information on the safety of BNT162b2 products for ...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2022-03-18
Trial ID
NCT05032976
Treatments Being Tested
This study, a pilot randomized controlled trial, single-blind (outcome asse...
Status
Completed
Location
Faculty of Medicine, Prince of Songkla University
Start Date
2024-03-01
Trial ID
NCT06831786
Treatments Being Tested
This clinical trial will be a blinded, randomised study to determine the sa...
Status
Withdrawn
Location
Royal Children's Hospital, Murdoch Children's Research Institute
Start Date
2022-05-02
Trial ID
NCT05543356
The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/...
Status
Active Not Recruiting
Location
The Medical City-Iloilo
Start Date
2023-11-27
Trial ID
NCT05993325
Treatments Being Tested
This is a randomized, multi-site, adaptive, open-label clinical trial compa...
Status
Terminated
Location
UCLA Medical Center: Division of Rheumatology
Start Date
2021-08-13
Trial ID
NCT05000216
Treatments Being Tested
This study is a large-scale investigation (Phase 3) into a new booster shot...
Status
Completed
Location
Alfa Medical Research
Start Date
2023-08-16
Trial ID
NCT05973006
This study is to assess the post-marketing safety of BNT162b2 products usin...
Status
Completed
Location
Pfizer
Start Date
2025-04-23
Trial ID
NCT06743334
The objective of the study is to evaluate the immunogenicity and safety of ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04-01
Trial ID
NCT05308602
Treatments Being Tested
The objective of this study is to evaluate the immunogenicity and safety of...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04-25
Trial ID
NCT05239975
The objective of this trial is to compare the immunogenicity and the safety...
Status
Unknown
Location
CIC 1417 Cochin-Pasteur
Start Date
2023-05-16
Trial ID
NCT05749926